Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-.kappa.B) activation

   
   

Incontinentia Pigmenti (IP) is a neurocutaneous genodermatosis that segregates as an X-linked dominant disorder with a high probability of prenatal male lethality. A locus in Xq28 containing NF-.kappa.B Essential Modulator, a gene product involved in the activation of NF-kB and central to many pro-inflammatory and apoptotic pathways, contains mutations in the majority of cases of IP. Disclosed are methods, compositions and kits directed to a defect in a NF-.kappa.B related disease such as IP.

Incontinentia Pigmenti (ip) будет neurocutaneous genodermatosis сегрегирует как Х-soedinenny1 доминантный разлад с высокой вероятностью пренатальной мыжской летальности. Локус в Xq28 содержа модулятор/демодулятор NF-.kappa.B необходимый, продукт гена, котор включили в активацию НФ-nF-kB и централь к много про-vospalitel6nyx и apoptotic pathways, содержит перегласовки в большинстве случаев ip. Показаны методы, составы и наборы сразу к дефекту в заболевании отнесенном NF-.kappa.B such as ip.

 
Web www.patentalert.com

< Process for charged particle beam micro-machining of copper

< Electrode-less dielectrophorises for polarizable particles

> Method for selective inactivation of viral replication

> Antithrombin protein and DNA sequences from black fly

~ 00147